TRVN

Trevena Stock Price

2.54
0.34 (15.45%)
2.54
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Trevena Inc TRVN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.34 15.45% 2.54 19:40:32
Close Price Low Price High Price Open Price Previous Close
2.60 2.22 2.67 2.22 2.20
Bid Price Ask Price Spread News
2.54 2.57 0.03 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
30,653 16,696,019 $ 2.41 $ 40,297,650 15,500,999 0.46 - 4.50
Last Trade Time Type Quantity Stock Price Currency
19:40:12 formt 2,318 $ 2.54 USD

Trevena Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 389.56M 153.37M 152.26M $ 31.00k $ - -0.27 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -23.54k 1.90%

more financials information »

Trevena News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TRVN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.792.671.752.128,923,1720.7541.9%
1 Month1.952.671.451.819,305,3910.5930.26%
3 Months1.744.501.342.2910,650,7210.8045.98%
6 Months0.59764.500.462.045,992,2851.94325.03%
1 Year1.004.500.461.933,369,5381.54154.0%
3 Years2.574.500.38231.682,280,533-0.03-1.17%
5 Years11.8113.570.38232.281,588,418-9.27-78.49%

Trevena Description

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.


Your Recent History
NASDAQ
TRVN
Trevena
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.